By Zachary Zagger ( March 31, 2015, 7:04 PM EDT) -- CoLucid Pharmaceuticals Inc., a biotech developing treatments for migraine headaches, filed a prospectus Monday with the U.S. Securities and Exchange Commission saying it is looking to raise $86 million in an initial public offering, as the company looks to cash in on the growing migraine treatments industry....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.